Crossmark

Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer

Published Online: 2022-03-29

Published Print: 2022-07-20

Authors

Lett, Lauren http://orcid.org/0000-0002-3623-0321
George, Michael http://orcid.org/0000-0002-5388-4634
Slater, Rachael

De Lacy Costello, Ben

Ratcliffe, Norman

García-Fiñana, Marta

Lazarowicz, Henry

Probert, Chris http://orcid.org/0000-0003-4550-0239
Funding

Funding for this research was provided by:

Cancer Research UK (C45856/A21068, C45856/A21068, C45856/A21068, C45856/A21068, C45856/A21068, C45856/A21068, C45856/A21068, C45856/A21068)
License Information

Text and Data Mining valid from 2022-03-29

Version of Record valid from 2022-03-29
More Information

Article History

Received: 19 October 2021

Revised: 21 February 2022

Accepted: 8 March 2022

First Online: 29 March 2022

Competing interests

: The authors declare no competing interests.

: Ethical approval was granted by the National Research Ethics Committee North West–Haydock (REC 14/NW/1212). Participants provided informed, written consent prior to enrolment. This study was performed in accordance with the Declaration of Helsinki.

: Not applicable.

Document is current